Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Claudio Anasetti

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Living Beings

Concepts & Ideas

Chemicals & Drugs

Physiology

Graft Survival

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gajewski James L; LeMaistre C Frederick; Silver Samuel M; Lill Michael C; Selby George B; Horowitz Mary M; Rizzo J Douglas; Heslop Helen E; Anasetti Claudio; Maziarz Richard T
Impending challenges in the hematopoietic stem cell transplantation physician workforce.
Pidala Joseph; Anasetti Claudio; Kharfan-Dabaja Mohamed A; Cutler Corey; Sheldon Andy; Djulbegovic Benjamin
Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.
Pidala Joseph; Kim Jongphil; Field Teresa; McBride Ali; Kharfan-Dabaja Mohamed; Perkins Janelle; Fernandez Hugo; Perez Lia; Ayala Ernesto; Anasetti Claudio
Infliximab for managing steroid-refractory acute graft-versus-host disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Claudio Anasetti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gajewski James L; LeMaistre C Frederick; Silver Samuel M; Lill Michael C; Selby George B; Horowitz Mary M; Rizzo J Douglas; Heslop Helen E; Anasetti Claudio; Maziarz Richard T
Impending challenges in the hematopoietic stem cell transplantation physician workforce.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1493-501.
2009: Pidala Joseph; Anasetti Claudio; Kharfan-Dabaja Mohamed A; Cutler Corey; Sheldon Andy; Djulbegovic Benjamin
Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1415-21.
2009: Pidala Joseph; Kim Jongphil; Field Teresa; McBride Ali; Kharfan-Dabaja Mohamed; Perkins Janelle; Fernandez Hugo; Perez Lia; Ayala Ernesto; Anasetti Claudio
Infliximab for managing steroid-refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1116-21.
2009: Salinger David H; Blough David K; Vicini Paolo; Anasetti Claudio; O'Donnell Paul V; Sandmaier Brenda M; McCune Jeannine S
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5280-7.
2009: Pidala Joseph; Kim Jongphil; Anasetti Claudio
Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):881-5.
2009: Yu Yu; Iclozan Cristina; Yamazaki Tomohide; Yang Xuexian; Anasetti Claudio; Dong Chen; Yu Xue-Zhong
Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death.
Blood 2009;114(5):1026-8.
2009: Pidala Joseph; Anasetti Claudio; Jim Heather
Quality of life after allogeneic hematopoietic cell transplantation.
Blood 2009;114(1):7-19.
2009: Carnevale-Schianca Fabrizio; Leisenring Wendy; Martin Paul J; Furlong Terry; Schoch Gary; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Kiem Hans-Peter; Storb Rainer; McDonald George B; Nash Richard A
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
2009: Anasetti Claudio
Selecting donor recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):393-4.
2009: Davies Stella M; Wang Dan; Wang Tao; Arora Muhkta; Ringden Olle; Anasetti Claudio; Pavletic Steven; Casper James; Macmillan Margaret L; Sanders Jean; Wall Donna; Kernan Nancy A
Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):360-6.
2008: Anasetti Claudio
What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?
Best practice & research. Clinical haematology 2008;21(4):691-7.
2008: Hahn Theresa; McCarthy Philip L; Zhang Mei-Jie; Wang Dan; Arora Mukta; Frangoul Haydar; Gale Robert Peter; Hale Gregory A; Horan John; Isola Luis; Maziarz Richard T; van Rood Jon J; Gupta Vikas; Halter Joerg; Reddy Vijay; Tiberghien Pierre; Litzow Mark; Anasetti Claudio; Pavletic Stephen; Ringdén Olle
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5728-34.
2008: Guo Fei; Iclozan Cristina; Suh Woong-Kyung; Anasetti Claudio; Yu Xue-Zhong
CD28 controls differentiation of regulatory T cells from naive CD4 T cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(4):2285-91.
2008: Weisdorf Daniel; Spellman Stephen; Haagenson Michael; Horowitz Mary; Lee Stephanie; Anasetti Claudio; Setterholm Michelle; Drexler Rebecca; Maiers Martin; King Roberta; Confer Dennis; Klein John
Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):748-58.
2008: Anasetti Claudio
Chemotherapy or allografting for young adults with high-risk ALL?
Blood 2008;111(12):5755; author reply 5755.
2008: Perez Lia Elena; Parquet Nancy; Shain Kenneth; Nimmanapalli Ramadevi; Alsina Melissa; Anasetti Claudio; Dalton William
Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(3):1545-55.
2008: Kamani Naynesh; Spellman Stephen; Hurley Carolyn Katovich; Barker Juliet N; Smith Franklin O; Oudshoorn Machteld; Bray Robert; Smith Anajane; Williams Thomas M; Logan Brent; Eapen Mary; Anasetti Claudio; Setterholm Michelle; Confer Dennis L;
State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):1-6.
2008: Liang Yaming; Liu Chen; Djeu Julie Y; Zhong Bin; Peters Thorsten; Scharffetter-Kochanek Karin; Anasetti Claudio; Yu Xue-Zhong
Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.
Blood 2008;111(2):954-62.
2007: Eapen Mary; Logan Brent R; Confer Dennis L; Haagenson Michael; Wagner John E; Weisdorf Daniel J; Wingard John R; Rowley Scott D; Stroncek David; Gee Adrian P; Horowitz Mary M; Anasetti Claudio
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1461-8.
2007: Lee Stephanie J; Klein John; Haagenson Michael; Baxter-Lowe Lee Ann; Confer Dennis L; Eapen Mary; Fernandez-Vina Marcelo; Flomenberg Neal; Horowitz Mary; Hurley Carolyn K; Noreen Harriet; Oudshoorn Machteld; Petersdorf Effie; Setterholm Michelle; Spellman Stephen; Weisdorf Daniel; Williams Thomas M; Anasetti Claudio
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Blood 2007;110(13):4576-83.
2007: Ferrara James L M; Anasetti Claudio; Stadtmauer Edward; Antin Joseph; Wingard John; Lee Stephanie; Levine John; Schultz Kirk; Appelbaum Frederick; Negrin Robert; Giralt Sergio; Bredeson Christopher; Heslop Helen; Horowitz Mary
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1268-85.
2007: Kharfan-Dabaja Mohamed A; Anasetti Claudio; Santos Edgardo S
Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):373-85.
2007: Kharfan-Dabaja Mohamed A; Anasetti Claudio; Ferrara James L M
Sympathectomy protects denervated skin from graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):369-70.
2007: Anasetti Claudio; Mulé James J
To ablate or not to ablate? HSCs in the T cell driver's seat.
The Journal of clinical investigation 2007;117(2):306-10.
2007: Jacobs Sheri R; Jacobsen Paul B; Booth-Jones Margaret; Wagner Lynne I; Anasetti Claudio
Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients.
Journal of pain and symptom management 2007;33(1):13-23.
2007: Kharfan-Dabaja M A; Ayala E; Greene J; Rojiani A; Murtagh F R; Anasetti C
Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.
Bone marrow transplantation 2007;39(2):101-7.
2006: Green Myke R; Anasetti Claudio; Sandin Ramon L; Rolfe Nancy E; Greene John N
Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2006;12(3):179-81.
2006: Farag Sherif S; Bacigalupo Andrea; Eapen Mary; Hurley Carolyn; Dupont Bo; Caligiuri Michael A; Boudreau Christian; Nelson Gene; Oudshoorn Machteld; van Rood Jon; Velardi Andrea; Maiers Martin; Setterholm Michelle; Confer Dennis; Posch Phillip E; Anasetti Claudio; Kamani Naynesh; Miller Jeffrey S; Weisdorf Daniel; Davies Stella M;
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):876-84.
2006: Yu Xue-Zhong; Liang Yaming; Nurieva Roza I; Guo Fei; Anasetti Claudio; Dong Chen
Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7394-401.
2006: Jones Roy B; Anasetti Claudio; Appel Peggy; DiPersio John; Heslop Helen; Lemaistre Fred; Silver Sam; Sirilla Janet; Stiff Patrick;
ASBMT committee report: white paper on measurement of quality outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):594-7.
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Albert Michael H; Anasetti Claudio; Yu Xue-Zhong
T regulatory cells as an immunotherapy for transplantation.
Expert opinion on biological therapy 2006;6(4):315-24.
2006: Yu Xue-Zhong; Albert Michael H; Anasetti Claudio
Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(6):3383-90.
2006: Anasetti Claudio
The 2006 BBMT Education Supplement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 1):1.
2006: Anasetti Claudio; Perkins Janelle; Nieder Michael L; Field Teresa
Are matched unrelated donor transplants justified for AML in CR1?
Best practice & research. Clinical haematology 2006;19(2):321-8.
2005: Yu Xue-Zhong; Anasetti Claudio
Memory stem cells sustain disease.
Nature medicine 2005;11(12):1282-3.
2005: Albert Michael H; Liu Yan; Anasetti Claudio; Yu Xue-Zhong
Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
European journal of immunology 2005;35(9):2598-607.
2005: Pavletic Steven Z; Khouri Issa F; Haagenson Michael; King Roberta J; Bierman Philip J; Bishop Michael R; Carston Michael; Giralt Sergio; Molina Arturo; Copelan Edward A; Ringdén Olle; Roy Vivek; Ballen Karen; Adkins Douglas R; McCarthy Philip; Weisdorf Daniel; Montserrat Emili; Anasetti Claudio
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5788-94.
2005: Field Teresa; Anasetti Claudio
Selection of unrelated donors for hematopoietic cell transplantation.
Current hematology reports 2005;4(4):270-5.
2005: Nash Richard A; Johnston Laura; Parker Pablo; McCune Jeannine S; Storer Barry; Slattery John T; Furlong Terry; Anasetti Claudio; Appelbaum Frederick R; Lloid Michele E; Deeg H Joachim; Kiem Hans-Peter; Martin Paul J; Schubert Mark M; Witherspoon Robert P; Forman Stephen J; Blume Karl G; Storb Rainer
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: Carpenter Paul A; Lowder James; Johnston Laura; Frangoul Haydar; Khoury Hanna; Parker Pablo; Jerome Keith R; McCune Jeannine S; Storer Barry; Martin Paul; Appelbaum Frederick; Abonour Rafat; Westervelt Peter; Anasetti Claudio
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):465-71.
2005: Albert Michael H; Yu Xue-Zhong; Martin Paul J; Anasetti Claudio
Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin.
Blood 2005;105(3):1355-61.
2004: Stewart Betty L; Storer Barry; Storek Jan; Deeg H Joachim; Storb Rainer; Hansen John A; Appelbaum Frederick R; Carpenter Paul A; Sanders Jean E; Kiem Hans-Peter; Nash Richard A; Petersdorf Effie W; Moravec Carina; Morton A James; Anasetti Claudio; Flowers Mary E D; Martin Paul J
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
2004: Petersdorf Effie W; Anasetti Claudio; Martin Paul J; Gooley Ted; Radich Jerald; Malkki Mari; Woolfrey Ann; Smith Anajane; Mickelson Eric; Hansen John A
Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
Blood 2004;104(9):2976-80.
2004: Flomenberg Neal; Baxter-Lowe Lee Ann; Confer Dennis; Fernandez-Vina Marcelo; Filipovich Alexandra; Horowitz Mary; Hurley Carolyn; Kollman Craig; Anasetti Claudio; Noreen Harriet; Begovich Ann; Hildebrand William; Petersdorf Effie; Schmeckpeper Barbara; Setterholm Michelle; Trachtenberg Elizabeth; Williams Thomas; Yunis Edmond; Weisdorf Daniel
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Blood 2004;104(7):1923-30.
2004: Martin Paul J; Pei Ji; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Deeg Joachim; Hansen John A; Nash Richard A; Petersdorf Effie W; Storb Rainer; Ghetie Victor; Schindler John; Vitetta Ellen S
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):552-60.
2004: Cutler Corey S; Lee Stephanie J; Greenberg Peter; Deeg H Joachim; Pérez Waleska S; Anasetti Claudio; Bolwell Brian J; Cairo Mitchell S; Gale Robert Peter; Klein John P; Lazarus Hillard M; Liesveld Jane L; McCarthy Philip L; Milone Gustavo A; Rizzo J Douglas; Schultz Kirk R; Trigg Michael E; Keating Armand; Weisdorf Daniel J; Antin Joseph H; Horowitz Mary M
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
Blood 2004;104(2):579-85.
2004: Yu Xue-Zhong; Albert Michael H; Martin Paul J; Anasetti Claudio
CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
The Journal of clinical investigation 2004;113(11):1624-30.
2004: Anasetti Claudio
Advances in the prevention of graft-versus-host disease after hematopoietic cell transplantation.
Transplantation 2004;77(9 Suppl):S79-83.
2004: Martin Paul J; McDonald George B; Sanders Jean E; Anasetti Claudio; Appelbaum Frederick R; Deeg H Joachim; Nash Richard A; Petersdorf Effie W; Hansen John A; Storb Rainer
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
2004: Yusuf U; Frangoul H A; Gooley T A; Woolfrey A E; Carpenter P A; Andrews R G; Deeg H J; Appelbaum F R; Anasetti C; Storb R; Sanders J E
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone marrow transplantation 2004;33(8):805-14.
2004: Yu Xue-Zhong; Levin Steven D; Madrenas Joaquin; Anasetti Claudio
Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1437-43.
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: Hurley Carolyn Katovich; Baxter Lowe Lee Ann; Logan Brent; Karanes Chatchada; Anasetti Claudio; Weisdorf Daniel; Confer Dennis L
National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):610-5.
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
2003: Maris Michael B; Niederwieser Dietger; Sandmaier Brenda M; Storer Barry; Stuart Monic; Maloney David; Petersdorf Effie; McSweeney Peter; Pulsipher Michael; Woolfrey Ann; Chauncey Thomas; Agura Ed; Heimfeld Shelly; Slattery John; Hegenbart Ute; Anasetti Claudio; Blume Karl; Storb Rainer
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
Blood 2003;102(6):2021-30.
2003: Bornhauser Martin; Storer Barry; Slattery John T; Appelbaum Frederick R; Deeg H Joachim; Hansen John; Martin Paul J; McDonald George B; Nichols W Garrett; Radich Jerald; Woolfrey Ann; Jenke Andreas; Schleyer Eberhard; Thiede Christian; Ehninger Gerhard; Anasetti Claudio
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.
Blood 2003;102(3):820-6.
2003: Arpinati Mario; Chirumbolo Gabriella; Urbini Benedetta; Perrone Giulia; Rondelli Damiano; Anasetti Claudio
Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.
Transplant immunology 2003;11(3-4):345-56.
2003: Anasetti Claudio
Advances in unrelated donor hematopoietic cell transplantation.
Haematologica 2003;88(3):246-9.
2003: Yu Xue-Zhong; Martin Paul J; Anasetti Claudio
CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(6):3002-6.
2003: Anasetti Claudio
Acquired tolerance to renal allografts in humans.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(3):243-4.
2003: McDonald George B; Slattery John T; Bouvier Michelle E; Ren Song; Batchelder Ami L; Kalhorn Thomas F; Schoch H Gary; Anasetti Claudio; Gooley Ted
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.
Blood 2003;101(5):2043-8.
2003: Niederwieser Dietger; Maris Michael; Shizuru Judith A; Petersdorf Effie; Hegenbart Ute; Sandmaier Brenda M; Maloney David G; Storer Barry; Lange Thoralf; Chauncey Thomas; Deininger Michael; Pönisch Wolfram; Anasetti Claudio; Woolfrey Ann; Little Marie-Terese; Blume Karl G; McSweeney Peter A; Storb Rainer F
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.
Blood 2003;101(4):1620-9.
2002: Rossi Marco; Arpinati Mario; Rondelli Damiano; Anasetti Claudio
Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?
Human immunology 2002;63(12):1194-200.
2002: Anasetti Claudio
Advances in unrelated donor hematopoietic cell transplantation: improved matching and use of blood stem cells.
Haematologica 2002;87(8 Suppl):1-3.
2002: McCune J S; Gooley T; Gibbs J P; Sanders J E; Petersdorf E W; Appelbaum F R; Anasetti C; Risler L; Sultan D; Slattery J T
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;30(3):167-73.
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Platzbecker Uwe; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Clurman Bruce; Doney Kris; Chauncey Thomas; Flowers Mary E D; Myerson David; Radich Jerald P; Storb Rainer; Witherspoon Robert P; Deeg H Joachim
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Tan Philip; Mitchell David A; Buss Timothy N; Holmes Margaret A; Anasetti Claudio; Foote Jefferson
"Superhumanized" antibodies: reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: application to an anti-CD28.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(2):1119-25.
2002: Koc Sibel; Leisenring Wendy; Flowers Mary E D; Anasetti Claudio; Deeg H Joachim; Nash Richard A; Sanders Jean E; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
2002: Carpenter Paul A; Appelbaum Frederick R; Corey Lawrence; Deeg H Joachim; Doney Kris; Gooley Theodore; Krueger James; Martin Paul; Pavlovic Sandra; Sanders Jean; Slattery John; Levitt Daniel; Storb Rainer; Woolfrey Ann; Anasetti Claudio
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Woolfrey Ann E; Anasetti Claudio; Storer Barry; Doney Kristine; Milner Laurie A; Sievers Eric L; Carpenter Paul; Martin Paul; Petersdorf Effie; Appelbaum Frederick R; Hansen John A; Sanders Jean E
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
Blood 2002;99(6):2002-8.
2002: Weisdorf Daniel J; Anasetti Claudio; Antin Joseph H; Kernan Nancy A; Kollman Craig; Snyder David; Petersdorf Effie; Nelson Gene; McGlave Philip
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Blood 2002;99(6):1971-7.
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: Petersdorf E W; Hansen J A; Martin P J; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
The New England journal of medicine 2001;345(25):1794-800.
2001: Yu X Z; Nitta Y; Bidwell S J; Anasetti C
Additive effects of anti-CD3 and anti-CD28 prolongation of allogeneic skin graft survival.
Transplantation 2001;72(11):1862.
2001: Kansu E; Gooley T; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
2001: Lee S J; Klein J P; Anasetti C; Antin J H; Loberiza F R; Bolwell B J; LeMaistre C F; Litzow M R; Marks D; Waller E K; Matlack M; Giralt S; Horowitz M M
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.
Blood 2001;98(12):3205-11.
2001: Kollman C; Howe C W; Anasetti C; Antin J H; Davies S M; Filipovich A H; Hegland J; Kamani N; Kernan N A; King R; Ratanatharathorn V; Weisdorf D; Confer D L
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Blood 2001;98(7):2043-51.
2001: Petersdorf E; Anasetti C; Martin P J; Woolfrey A; Smith A; Mickelson E; Malkki M; Lin M T; Hansen J A
Genomics of unrelated-donor hematopoietic cell transplantation.
Current opinion in immunology 2001;13(5):582-9.
2001: Ohishi K; Varnum-Finney B; Serda R E; Anasetti C; Bernstein I D
The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells.
Blood 2001;98(5):1402-7.
2001: Yu X; Carpenter P; Anasetti C
Advances in transplantation tolerance.
Lancet 2001;357(9272):1959-63.
2001: Yu X Z; Bidwell S J; Martin P J; Anasetti C
Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(9):5835-9.
2001: Witherspoon R P; Deeg H J; Storer B; Anasetti C; Storb R; Appelbaum F R
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2134-41.
2001: Petersdorf E W; Gooley T; Malkki M; Anasetti C; Martin P; Woolfrey A; Smith A; Mickelson E; Hansen J A
The biological significance of HLA-DP gene variation in haematopoietic cell transplantation.
British journal of haematology 2001;112(4):988-94.
2001: Cornelissen J J; Carston M; Kollman C; King R; Dekker A W; Löwenberg B; Anasetti C
Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome.
Blood 2001;97(6):1572-7.
2001: Jurado M; Deeg H; Gooley T; Anasetti C; Chauncey T; Flowers M; Myerson D; Storb R; Appelbaum F
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: Pei J; Akatsuka Y; Anasetti C; Lin M T; Petersdorf E W; Hansen J A; Martin P J
Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(7):378-83.
2001: Deeg H J; Amylon I D; Harris R E; Collins R; Beatty P G; Feig S; Ramsay N; Territo M; Khan S P; Pamphilon D; Leis J F; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):208-15.
2000: Davies S M; Kollman C; Anasetti C; Antin J H; Gajewski J; Casper J T; Nademanee A; Noreen H; King R; Confer D; Kernan N A
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.
Blood 2000;96(13):4096-102.
2000: Koc S; Leisenring W; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
2000: Carpenter P A; Pavlovic S; Tso J Y; Press O W; Gooley T; Yu X Z; Anasetti C
Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6205-13.
2000: Sierra J; Bjerke J; Hansen J; Martin P; Petersdorf E; Woolfrey A; Anasetti C
Marrow transplants from unrelated donors as treatment for acute leukemia.
Leukemia & lymphoma 2000;39(5-6):495-507.
2000: Carpenter P A; Tso J Y; Press O W; Yu X; Anasetti C
Non-FcR-binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo.
Transplantation proceedings 2000;32(7):1545-6.
2000: Furlong T; Storb R; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K; Witherspoon R; Nash R A
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
2000: Nash R A; Antin J H; Karanes C; Fay J W; Avalos B R; Yeager A M; Przepiorka D; Davies S; Petersen F B; Bartels P; Buell D; Fitzsimmons W; Anasetti C; Storb R; Ratanatharathorn V
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Blood 2000;96(6):2062-8.
2000: Sierra J; Storer B; Hansen J A; Martin P J; Petersdorf E W; Woolfrey A; Matthews D; Sanders J E; Storb R; Appelbaum F R; Anasetti C
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Bone marrow transplantation 2000;26(4):397-404.
2000: Zang D Y; Deeg H J; Gooley T; Anderson J E; Anasetti C; Sanders J; Myerson D; Storb R; Appelbaum F
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
British journal of haematology 2000;110(1):217-22.
2000: Yu X Z; Bidwell S J; Martin P J; Anasetti C
CD28-specific antibody prevents graft-versus-host disease in mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4564-8.
2000: Ohishi K; Varnum-Finney B; Flowers D; Anasetti C; Myerson D; Bernstein I D
Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.
Blood 2000;95(9):2847-54.
2000: Arpinati M; Green C L; Heimfeld S; Heuser J E; Anasetti C
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
Blood 2000;95(8):2484-90.
2000: Anasetti C
Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(3):502-4.
2000: Mickelson E M; Petersdorf E; Anasetti C; Martin P; Woolfrey A; Hansen J A
HLA matching in hematopoietic cell transplantation.
Human immunology 2000;61(2):92-100.
2000: Deeg H J; Shulman H M; Anderson J E; Bryant E M; Gooley T A; Slattery J T; Anasetti C; Fefer A; Storb R; Appelbaum F R
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Yu X Z; Anasetti C
Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2.
Transplantation 2000;69(1):104-12.
2000: Carnevale-Schianca F; Martin P; Sullivan K; Flowers M; Gooley T; Anasetti C; Deeg J; Furlong T; McSweeney P; Storb R; Nash R A
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):613-20.
2000: Flowers M E; Leisenring W; Beach K; Riddell S; Radich J P; Higano C S; Rowley S D; Chauncey T R; Sanders J E; Anasetti C; Storb R; Wade J; Appelbaum F R; Martin P
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):321-6.
2000: Radich J P; Gooley T; Sanders J E; Anasetti C; Chauncey T; Appelbaum F R
Second allogeneic transplantation after failure of first autologous transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):272-9.
1999: Matsumoto K; Anasetti C
The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
Leukemia & lymphoma 1999;35(5-6):427-35.
1999: Yu X Z; Bidwell S; Martin P J; Anasetti C
Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(9):4780-7.
1999: Petersdorf E W; Mickelson E M; Anasetti C; Martin P J; Woolfrey A E; Hansen J A
Effect of HLA mismatches on the outcome of hematopoietic transplants.
Current opinion in immunology 1999;11(5):521-6.
1999: Martin P J; Rowley S D; Anasetti C; Chauncey T R; Gooley T; Petersdorf E W; van Burik J A; Flowers M E; Storb R; Appelbaum F R; Hansen J A
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
1999: Woolfrey A E; Anasetti C; Petersdorf E W; Martin P J; Sanders J E; Hansen J A
Unrelated donor marrow transplantation for treatment of childhood hematologic malignancies-effect of HLA disparity and cell dose.
Cancer treatment and research 1999;101():25-51.
1999: Feinstein L C; Seidel K; Jocum J; Bowden R A; Anasetti C; Deeg H J; Flowers M E; Kansu E; Martin P J; Nash R A; Storek J; Etzioni R; Applebaum F R; Hansen J A; Storb R; Sullivan K M
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):369-78.
1999: Woolfrey A; Anasetti C
Allogeneic hematopoietic stem-cell engraftment and graft failure.
Pediatric transplantation 1999;3 Suppl 1():35-40.
1999: Deeg H J; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski J L; Territo M; Ramsay N; Harris R E; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):243-52.
1998: Woolfrey A E; Gooley T A; Sievers E L; Milner L A; Andrews R G; Walters M; Hoffmeister P; Hansen J A; Anasetti C; Bryant E; Appelbaum F R; Sanders J E
Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Blood 1998;92(10):3546-56.
1998: Petersdorf E W; Gooley T A; Anasetti C; Martin P J; Smith A G; Mickelson E M; Woolfrey A E; Hansen J A
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.
Blood 1998;92(10):3515-20.
1998: Martin P J; Schoch G; Gooley T; Anasetti C; Deeg H J; Nash R; Sanders J; Storb R; Appelbaum F
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
1998: Yu X Z; Martin P J; Anasetti C
Role of CD28 in acute graft-versus-host disease.
Blood 1998;92(8):2963-70.
1998: Stucki A; Leisenring W; Sandmaier B M; Sanders J; Anasetti C; Storb R
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Blood 1998;92(8):2742-9.
1998: Ren S; Kalhorn T F; McDonald G B; Anasetti C; Appelbaum F R; Slattery J T
Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients.
Clinical pharmacology and therapeutics 1998;64(3):289-301.
1998: Morton A J; Gooley T; Hansen J A; Appelbaum F R; Bruemmer B; Bjerke J W; Clift R; Martin P J; Petersdorf E W; Sanders J E; Storb R; Sullivan K M; Woolfrey A; Anasetti C
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Blood 1998;92(2):394-401.
1998: Sullivan K M; Anasetti C; Horowitz M; Rowlings P A; Petersdorf E W; Martin P J; Clift R A; Walters M C; Gooley T; Sierra J; Anderson J E; Bjerke J; Siadak M; Flowers M E; Nash R A; Sanders J E; Appelbaum F R; Storb R; Hansen J A
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
Annals of the New York Academy of Sciences 1998;850():312-24.
1998: Ryncarz R E; Anasetti C
Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells.
Blood 1998;91(10):3892-900.
1998: Hansen J A; Gooley T A; Martin P J; Appelbaum F; Chauncey T R; Clift R A; Petersdorf E W; Radich J; Sanders J E; Storb R F; Sullivan K M; Anasetti C
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
1998: Martin P J; Gooley T; Anasetti C; Petersdorf E W; Hansen J A
HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):128-33.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Pei J; Martin P J; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):142-9.
1997: Sierra J; Radich J; Hansen J A; Martin P J; Petersdorf E W; Bjerke J; Bryant E; Nash R A; Sanders J E; Storb R; Sullivan K M; Appelbaum F R; Anasetti C
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 1997;90(4):1410-4.
1997: Clift R A; Anasetti C
Allografting for chronic myeloid leukaemia.
Baillière's clinical haematology 1997;10(2):319-36.
1997: Sierra J; Storer B; Hansen J A; Bjerke J W; Martin P J; Petersdorf E W; Appelbaum F R; Bryant E; Chauncey T R; Sale G; Sanders J E; Storb R; Sullivan K M; Anasetti C
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
1997: Deeg H J; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum F R; Chauncey T R; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan K M; Witherspoon R P; Storb R
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: Anderson J E; Gooley T A; Schoch G; Anasetti C; Bensinger W I; Clift R A; Hansen J A; Sanders J E; Storb R; Appelbaum F R
Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Blood 1997;89(7):2578-85.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Petersdorf E W; Longton G M; Anasetti C; Mickelson E M; McKinney S K; Smith A G; Martin P J; Hansen J A
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.
Blood 1997;89(5):1818-23.
1996: Petersdorf E W; Longton G M; Anasetti C; Mickelson E M; Smith A G; Martin P J; Hansen J A
Definition of HLA-DQ as a transplantation antigen.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15358-63.
1996: Nash R A; Piñeiro L A; Storb R; Deeg H J; Fitzsimmons W E; Furlong T; Hansen J A; Gooley T; Maher R M; Martin P; McSweeney P A; Sullivan K M; Anasetti C; Fay J W
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.
Blood 1996;88(9):3634-41.
1996: Yu X Z; Zhu L; Davis J E; Tso J Y; Hansen J A; Anasetti C
Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(8):3420-9.
1996: Bensinger W I; Buckner C D; Anasetti C; Clift R; Storb R; Barnett T; Chauncey T; Shulman H; Appelbaum F R
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: Rondelli D; Andrews R G; Hansen J A; Ryncarz R; Faerber M A; Anasetti C
Alloantigen presenting function of normal human CD34+ hematopoietic cells.
Blood 1996;88(7):2619-75.
1996: Martin P J; Nelson B J; Appelbaum F R; Anasetti C; Deeg H J; Hansen J A; McDonald G B; Nash R A; Sullivan K M; Witherspoon R P; Scannon P J; Friedmann N; Storb R
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
1996: Anderson J E; Anasetti C; Appelbaum F R; Schoch G; Gooley T A; Hansen J A; Buckner C D; Sanders J E; Sullivan K M; Storb R
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
British journal of haematology 1996;93(1):59-67.
1996: Langston A A; Sanders J E; Deeg H J; Crawford S W; Anasetti C; Sullivan K M; Flowers M E; Storb R
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
British journal of haematology 1996;92(3):758-65.
1996: Sullivan K M; Storek J; Kopecky K J; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon R P; Anasetti C; Appelbaum F R; Bowden R A; Buckner C D; Crawford S W; Deeg H J; Hansen J A; McDonald G B; Sanders J E; Storb R
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: Mickelson E M; Longton G; Anasetti C; Petersdorf E; Martin P; Guthrie L A; Hansen J A
Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation.
Tissue antigens 1996;47(1):27-36.
1996: Wagner J L; Deeg H J; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan K M; Storb R
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
Transplantation 1996;61(1):54-61.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T; Clift R A
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1996: Chalupny N J; Zhu L; Yu X Z; Anasetti C
Cell cycle control of T cell apoptosis induced by activation through the T cell antigen receptor.
Advances in experimental medicine and biology 1996;406():57-67.
1995: Balduzzi A; Gooley T; Anasetti C; Sanders J E; Martin P J; Petersdorf E W; Appelbaum F R; Buckner C D; Matthews D; Storb R; Sullivan K M; Hansen J A
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
1995: Appelbaum F R; Clift R; Radich J; Anasetti C; Buckner C D
Bone marrow transplantation for chronic myelogenous leukemia.
Seminars in oncology 1995;22(4):405-11.
1995: Petersdorf E W; Longton G M; Anasetti C; Martin P J; Mickelson E M; Smith A G; Hansen J A
The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
Blood 1995;86(4):1606-13.
1995: Doney K C; Storb R; Beach K; Anasetti C; Deeg H J; Hansen J A; Martin P J; Nash R A; Schubert M M; Sullivan K M
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Transplantation 1995;60(1):55-8.
1995: Slattery J T; Sanders J E; Buckner C D; Schaffer R L; Lambert K W; Langer F P; Anasetti C; Bensinger W I; Fisher L D; Appelbaum F R
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.
Bone marrow transplantation 1995;16(1):31-42.
1995: Nash R A; Etzioni R; Storb R; Furlong T; Gooley T; Anasetti C; Appelbaum F R; Doney K; Martin P; Slattery J
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Blood 1995;85(12):3746-53.
1995: Demirer T; Weaver C H; Buckner C D; Petersen F B; Bensinger W I; Sanders J; Clift R A; Lilleby K; Anasetti C; Martin P
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):596-602.
1995: Fay J W; Nash R A; Wingard J R; Przepiorka D; Collins R H; Anasetti C; Devine S M; Piñeiro L A; Storb R F; Aro R M
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Transplantation proceedings 1995;27(1):1374.
1995: Zhu L; Anasetti C
Cell cycle control of apoptosis in human leukemic T cells.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):192-200.
1995: Hansen J A; Mickelson E; Petersdorf E W; Anderson J; Sierra J; Martin P J; Anasetti C
Marrow transplants from unrelated donors.
Clinical transplants 1995;():279-89.
1995: Anasetti C; Etzioni R; Petersdorf E W; Martin P J; Hansen J A
Marrow transplantation from unrelated volunteer donors.
Annual review of medicine 1995;46():169-79.
1995: Anasetti C; Petersdorf E W; Martin P J; Hansen J A
Marrow transplantation from unrelated volunteer donors.
Cancer treatment and research 1995;76():137-68.
1994: Clift R A; Buckner C D; Thomas E D; Bryant E; Anasetti C; Bensinger W I; Bowden R; Deeg H J; Doney K C; Fisher L D
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
Blood 1994;84(12):4368-73.
1994: Anasetti C; Hansen J A
Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
Transfusion science 1994;15(3):221-30.
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Mickelson E M; Guthrie L A; Etzioni R; Anasetti C; Martin P J; Hansen J A
Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
Tissue antigens 1994;44(2):83-92.
1994: Hansen J A; Anasetti C; Petersdorf E; Clift R A; Martin P J
Marrow transplants from unrelated donors.
Transplantation proceedings 1994;26(3):1710-2.
1994: Anasetti C; Howe C; Petersdorf E W; Martin P J; Hansen J A
Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.
Bone marrow transplantation 1994;13(6):693-5.
1994: Busca A; Anasetti C; Anderson G; Appelbaum F R; Buckner C D; Doney K; Martin P J; Petersdorf E; Sanders J E; Hansen J A
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
1994: Storb R; Leisenring W; Deeg H J; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Doney K; Hansen J
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Blood 1994;83(9):2749-50.
1994: Bearman S I; Mori M; Beatty P G; Meyer W G; Buckner C D; Petersen F B; Sanders J E; Anasetti C; Martin P; Appelbaum F R
Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bone marrow transplantation 1994;13(1):31-5.
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Anderson J E; Appelbaum F R; Fisher L D; Schoch G; Shulman H; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Doney K
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Weaver C H; Appelbaum F R; Petersen F B; Clift R; Singer J; Press O; Bensinger W; Bianco J; Martin P; Anasetti C
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1329-35.
1993: Voltarelli J C; Gjerset G; Anasetti C
Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.
Immunology 1993;79(3):509-11.
1993: Petersdorf E W; Smith A G; Mickelson E M; Longton G M; Anasetti C; Choo S Y; Martin P J; Hansen J A
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Blood 1993;81(7):1923-32.
1993: Mickelson E M; Anasetti C; Yoon Choo S; Longton G M; Petersdorf E W; Martin P J; Hansen J A
Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
Transplantation proceedings 1993;25(1 Pt 2):1239-40.
1993: Petersdorf E W; Smith A G; Mickelson E M; Longton G M; Anasetti C; Choo S Y; Martin P J; Hansen J A
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1230-1.
1993: Beatty P G; Anasetti C; Hansen J A; Longton G M; Sanders J E; Martin P J; Mickelson E M; Choo S Y; Petersdorf E W; Pepe M S
Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.
Blood 1993;81(1):249-53.
1993: Tan P; Anasetti C; Hansen J A; Melrose J; Brunvand M; Bradshaw J; Ledbetter J A; Linsley P S
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
The Journal of experimental medicine 1993;177(1):165-73.
1993: Hansen J A; Anasetti C; Martin P J; Mickelson E M; Petersdorf E; Thomas E D
Allogeneic marrow transplantation: the Seattle experience.
Clinical transplants 1993;():193-209.
1992: Linsley P S; Greene J L; Tan P; Bradshaw J; Ledbetter J A; Anasetti C; Damle N K
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
The Journal of experimental medicine 1992;176(6):1595-604.
1992: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Davis J; Doney K; Hill H F; Stewart P; Sullivan K M
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
1992: Nash R A; Pepe M S; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum F R; Bowden R A; Deeg H J; Doney K
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Storb R; Pepe M; Deeg H J; Anasetti C; Appelbaum F R; Bensinger W; Buckner C D; Cliff R A; Doney K; Hansen J
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Blood 1992;80(2):560-1.
1992: Doney K; Pepe M; Storb R; Bryant E; Anasetti C; Appelbaum F R; Buckner C D; Sanders J; Singer J; Sullivan K
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
British journal of haematology 1992;80(1):49-54.
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1992: Sullivan K M; Mori M; Sanders J; Siadak M; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W; Bowden R; Buckner C D
Late complications of allogeneic and autologous marrow transplantation.
Bone marrow transplantation 1992;10 Suppl 1():127-34.
1991: Sullivan K M; Agura E; Anasetti C; Appelbaum F; Badger C; Bearman S; Erickson K; Flowers M; Hansen J; Loughran T
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Seminars in hematology 1991;28(3):250-9.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Calori E; Davis J; Doney K; Reichert T; Stewart P
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
1991: Clift R A; Buckner C D; Appelbaum F R; Bryant E; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.
Blood 1991;77(8):1660-5.
1991: Anasetti C
The role of the immunogenetics laboratory in marrow transplantation.
Archives of pathology & laboratory medicine 1991;115(3):288-92.
1991: Beatty P G; Hansen J A; Longton G M; Thomas E D; Sanders J E; Martin P J; Bearman S I; Anasetti C; Petersdorf E W; Mickelson E M
Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.
Transplantation 1991;51(2):443-7.
1990: Anasetti C; Tan P; Hansen J A; Martin P J
Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.
The Journal of experimental medicine 1990;172(6):1691-700.
1990: Clift R A; Buckner C D; Appelbaum F R; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I; Doney K
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
1990: Anasetti C; Beatty P G; Storb R; Martin P J; Mori M; Sanders J E; Thomas E D; Hansen J A
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
Human immunology 1990;29(2):79-91.
1990: Martin P J; Schoch G; Fisher L; Byers V; Anasetti C; Appelbaum F R; Beatty P G; Doney K; McDonald G B; Sanders J E
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Blood 1990;76(8):1464-72.
1990: Storb R; Pepe M; Anasetti C; Appelbaum F R; Beatty P; Doney K; Martin P; Stewart P; Sullivan K M; Witherspoon R
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Blood 1990;76(5):1037-45.
1990: Schmid I; Anasetti C; Petersen F B; Storb R
Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine.
Blut 1990;61(2-3):52-4.
1990: Hansen J A; Anasetti C; Beatty P G; Martin P J; Sanders J E; Storb R; Thomas E D
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Bone marrow transplantation 1990;6 Suppl 1():108-11.
1990: Storb R; Appelbaum F; Buckner C D; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Tan P; Anasetti C; Martin P J; Hansen J A
Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):485-8.
1990: Appelbaum F R; Barrall J; Storb R; Fisher L D; Schoch G; Ramberg R E; Shulman H; Anasetti C; Bearman S I; Beatty P
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Annals of internal medicine 1990;112(8):590-7.
1989: Sanders J; Sullivan K; Witherspoon R; Doney K; Anasetti C; Beatty P; Petersen F B
Long term effects and quality of life in children and adults after marrow transplantation.
Bone marrow transplantation 1989;4 Suppl 4():27-9.
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1989: Sullivan K M; Weiden P L; Storb R; Witherspoon R P; Fefer A; Fisher L; Buckner C D; Anasetti C; Appelbaum F R; Badger C
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Blood 1989;73(6):1720-8.
1989: Beatty P G; Hansen J A; Anasetti C; Sanders J; Buckner C D; Storb R; Thomas E D
Marrow transplantation from unrelated HLA-matched volunteer donors.
Transplantation proceedings 1989;21(1 Pt 3):2993-4.
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
1989: Buckner C D; Sanders J E; Anasetti C; Beatty P; Hansen J A; Storb R; Clift R; Thomas E D
Donors other than HLA-identical siblings.
Progress in clinical and biological research 1989;309():383-90.
1989: Sullivan K M; Buckner C D; Sanders J E; Anasetti C; Appelbaum F R; Clark J; Doney K; Meyers J; Sale G; Storb R
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1989: Hansen J A; Anasetti C; Beatty P G; Martin P J; Thomas E D
Allogeneic marrow transplantation: the Seattle experience.
Clinical transplants 1989;():105-14.
1988: Sullivan K M; Witherspoon R P; Storb R; Deeg H J; Dahlberg S; Sanders J E; Appelbaum F R; Doney K C; Weiden P; Anasetti C
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1987: Badger C C; Anasetti C; Davis J; Bernstein I D
Treatment of malignancy with unmodified antibody.
Pathology and immunopathology research 1987;6(5-6):419-34.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Claudio Anasetti

Research Profile (preview)

Disorders

Procedures

Living Beings

Concepts & Ideas

Chemicals & Drugs

Physiology

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Claudio Anasetti (preview)

All Publications